(Total Views: 477)
Posted On: 04/15/2020 5:22:48 PM
Post# of 145906
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
HCIT, this Vanda trial being covered on CNBC (instead of covering Leronlimab) would have really frustrated me too, especially since the Vanda drug has huge toxicity issues per the FDA; the FDA stopped one of their trials early for another application because of toxicity concerns.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)